Clinical trial · Interventional
Molecular Characterization of Carbapenemase-Producing Enterobacterales
Molecular Characterization of Carbapenemase-Producing Enterobacterales Isolated From Clinical Samples in Egypt
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Bacterial infections with carbapenem resistant pathogens are one of the major threats in immunocompromised patients, especially among cancer patients .Furthermore, Gram negative pathogens are becoming increasingly prevalent and have become an ongoing global health concern .Emergence of Gram-negative pathogens, especially Enterobacterales that avert many of the human defense mechanisms are alarmingly increasing and most of these pathogens are resistant to many of the in-use antibiotics including carbapenems .
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Myeloid Leukemia | Acute Myeloid Leukemia | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Antibiotic administration | Diagnostic Test | — | UNRESOLVED |
| Molecular detection of antibiotic resistance | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group 1 Patients with enterobacterials infections
- interventionNames
- Diagnostic Test: Antibiotic administration
- Diagnostic Test: Molecular detection of antibiotic resistance
- type
- EXPERIMENTAL
- label
- Group 2 patients with other bacterial infections
- interventionNames
- Diagnostic Test: Antibiotic administration
- Diagnostic Test: Molecular detection of antibiotic resistance
Primary outcomes (1)
- measure
- Isolation of causative organism
- timeFrame
- 6 months
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 4 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * All patients admitted to Sohag Oncology Center have different infections and isolated organism one of carbapenem resistant enterobacterales detected by antibiotic sensitivity test. Exclusion Criteria: * All patients admitted to Sohag Oncology Center having infections in different sites and isolated organisms are not one of enterobacterales and not carbapenem resistant.
References
Publications (0)
Data not yet available